ClinVar Miner

Submissions for variant NM_014908.4(DOLK):c.292C>T (p.Arg98Trp)

gnomAD frequency: 0.00001  dbSNP: rs747555089
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000688325 SCV000815931 uncertain significance DK1-congenital disorder of glycosylation 2022-11-15 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DOLK protein function. ClinVar contains an entry for this variant (Variation ID: 568082). This variant has not been reported in the literature in individuals affected with DOLK-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 98 of the DOLK protein (p.Arg98Trp).
Ambry Genetics RCV002440433 SCV002748783 uncertain significance Cardiovascular phenotype 2021-09-10 criteria provided, single submitter clinical testing The p.R98W variant (also known as c.292C>T), located in coding exon 1 of the DOLK gene, results from a C to T substitution at nucleotide position 292. The arginine at codon 98 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Fulgent Genetics, Fulgent Genetics RCV000688325 SCV002779135 uncertain significance DK1-congenital disorder of glycosylation 2021-09-15 criteria provided, single submitter clinical testing
GeneDx RCV004719946 SCV005325605 uncertain significance not provided 2024-09-16 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.